Veritas In Silico Inc.
|
| Code |
Sector |
Market |
Lead Underwriter |
Date of listing approval |
IPO Date |
| 130A |
Pharmaceuticals |
Growth |
Mizuho |
2024/01/05 |
2024/02/08 |
| 【Description】 |
| |
IPO Information |
| Opening Price |
Y2,001 |
Total Amount |
Y920,000,000 |
| IPO Price |
Y1,000 |
--Company |
Y736,000,000 |
Aggregate Value
(based on Initial Price) |
12,609
(Unit:1 million) |
--Leading Shareholder |
Y110,400,000 |
| Listed Shares(total) |
920,000 |
--Lead Manager |
Y73,600,000 |
| Trading Unit |
100 |
|
Offering Price PER
(based on previous period) |
-38.91 |
Offering Price PBR
(based on previous period) |
3.57 |
| 公開価格PER(今期予想ベース) |
176.37 |
| Initial Price PER |
-77.86 |
Initial Price PBR |
7.14 |
| New Shares |
800,000 |
Existing Shares |
120,000（only O.A.） |
| Shares Outstanding |
Pre IPO |
5,501,314.00 |
PostIPO |
6,301,314.00 |
| Paid Up Capital |
PreIPO |
Y90,000,000 |
PostIPO |
Y312,548,000 |
| Use of Funds Raised |
|
Financial Data |
| Units:Y1,000 |
| Fiscal Year End |
|
Revenue |
Current Profit |
Net Profit |
Net Assets |
| 2020/12 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
13,326 |
-297,034 |
-297,905 |
516,291 |
| 2021/12 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
59,330 |
-240,082 |
-232,319 |
1,683,971 |
| 2022/12 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
178,801 |
-138,455 |
-141,381 |
1,542,590 |
Recent Quarter
2023/09 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
279,251 |
37,888 |
35,750 |
1,578,341 |
Results Forecast
2023/12 |
Consolidated |
- |
- |
- |
- |
| Non-consolidated |
359,000 |
34,000 |
31,000 |
- |
| Per Share |
Units:Y1 |
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
| 2020/12 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-68.00 |
117.84 |
|
| 2021/12 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-51.92 |
306.10 |
|
| 2022/12 |
Consolidated |
0.00 |
- |
- |
|
| Non-consolidated |
-25.70 |
280.40 |
|
| Fiscal Year End |
|
Dividend |
Net Earning |
Equity |
|
Recent Quarter
2023/09 |
Consolidated |
|
- |
- |
|
| Non-consolidated |
6.50 |
- |
|
Results Forecast
2023/12
| Consolidated
| 0.00 |
- |
- |
|
| Non-consolidated |
5.67 |
- |
|
Comment |
| ■Over allotment(120,000） |
| Consolidated Subsidiaries |
| Name |
Address |
| Underwriters |
| Allocation |
Underwriter |
Tel |
| 93.3% |
Mizuho |
03-5208-3210 |
| 2% |
SMBC Nikko |
03-5644-3111 |
| 2% |
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. |
03-6213-8500 |
| 1.1% |
Rakuten Securities |
03-6406-2681 |
| 1.1% |
Matsui |
03-5216-0606 |
| 0.5% |
Akatsuki Securities |
03-5641-7800 |
| Major Shareholders |
| Shareholder Name |
Ratio |
| |
23.33% |
| |
11.96% |
| |
9.10% |
| |
8.39% |
| |
8.15% |
| |
5.63% |
| |
4.88% |
| |
4.68% |
| |
3.93% |
| |
3.40% |
| Number of Employees |
15 as of 2023/11/30 |
| Birth Date of Representative |
1972/06/07 |
|
|
IPO最新情報、セミナー・イベント情報などをタイムリーにお届けします。
|
|
IPO関連ニュースをX（旧Twitter）でも掲載中。初値予想アンケートも実施中です！
|
|
今後の躍進が期待される注目銘柄のアナリストレポートをご覧いただけます。
|
|
個人投資家向けIRセミナーを開催しませんか？開催希望企業募集中！
|
|
